Post job

Explore jobs

Find specific jobs

Explore careers

Explore professions

Best companies

Explore companies

Working at Stemline Therapeutics

Zippia score 3.6

Overview

SalaryRevenue

Reviews

CEO & Executives

Stemline Therapeutics overview

Industry
Biotechnology
Revenue
$43.2M
Headquarters
Employees
100
Founded in
Website
Organization type
Public
CEO
Ivan Bergstein
Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company and a leading developer of novel oncology compounds directed to cancer stem cell targets. Stemline's lead compound, SL-401, targets the interleukin-3 receptor present on multiple hematological cancers including leukemia blasts and leukemia cancer stem cells. SL-401 has demonstrated single agent anti-tumor activity at tolerable doses in a multi-center Phase I human trial. Behind its lead, Stemline is developing a broad portfolio of compounds directed at this and other high value cancer stem cell targets of a variety of hematological and solid cancers. In addition, Stemline has built a robust discovery platform called “StemScreen ” which the Company has utilized to identify multiple compounds that target and impair cancer stem cells. Stemline also possesses a comprehensive intellectual property portfolio that includes the earliest filings in the cancer stem cell field covering cancer stem cell-directed therapeutics, diagnostics, and drug screening.
Based in New York, NY, Stemline Therapeutics is a small health care company with only 100 employees and an annual revenue of $43.2M.

Stemline Therapeutics's mission statement

To build a leading biopharmaceutical company focused on greatly improving the lives of cancer patients by developing and commercializing innovative drugs that target cancer stem cells (CSCs) and tumor bulk.

In demand companies are hiring! Let Zippia apply for you!

Floating question marks illustration
-

Stemline Therapeutics employee reviews

Be the first to review!

Do you work at Stemline Therapeutics?

Help job seekers learn about working at Stemline Therapeutics

On this page

Be the first to review Stemline Therapeutics

Anonymously rate your employee experience

Your opinion can help other job seekers

Do you like working at Stemline Therapeutics?

The team at Stemline Therapeutics

  • The founders of Stemline Therapeutics are Ivan Bergstein and Eric Rowinsky M.d.
  • The key people at Stemline Therapeutics are Ivan Bergstein and Eric Rowinsky M.d.
Key people
Ivan Bergstein
Eric Rowinsky M.d

Stemline Therapeutics salaries

Average Stemline Therapeutics salary
$45,419
yearly
$21.84 hourly
Updated March 14, 2024

Rate the Stemline Therapeutics' inclusivity.

Zippia waving zebra

Do you work at Stemline Therapeutics?

Is Stemline Therapeutics' workforce diverse and inclusive?

Stemline Therapeutics financial performance

4.3
Performance score

We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

Stemline Therapeutics currently has 43.2M in revenue. Stemline Therapeutics's most recent quarter produced 8.9m (q1'2020).

Stemline Therapeutics annual revenue

$43M
$35M
$26M
$17M
$9M
$0
2019

Are you an executive, HR leader, or brand manager at Stemline Therapeutics?

Claiming and updating your company profile on Zippia is free and easy.

Stemline Therapeutics FAQs

Have more questions? See all answers to common company questions.

Search for jobs

Cities with Stemline Therapeutics jobs

Related companies

Related company jobs

Related company salaries

    Updated March 14, 2024

    Zippia gives an in-depth look into the details of Stemline Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Stemline Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Stemline Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Stemline Therapeutics. The data presented on this page does not represent the view of Stemline Therapeutics and its employees or that of Zippia.

    Stemline Therapeutics may also be known as or be related to STEMLINE THERAPEUTICS INC, Stemline Therapeutics, Stemline Therapeutics Inc, Stemline Therapeutics Inc. and Stemline Therapeutics, Inc.